Clinical Trials Browser

Phase 1 × Advanced or Recurrent Solid Tumors × Clear all

NCT06541639 2025-03-18

EVM16 Injection As a Single and Combination with Tislelizumab in Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Advanced or Recurrent Solid Tumors

NCT01285453 2020-12-09

Safety and Tolerability of ASA404 Administered in Combination With Docetaxel in Japanese Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Advanced or Recurrent Solid Tumors